Insights On Drug Discovery

  1. An Alternative Genetic Engineering Tool In CHO Cells 8/15/2025

    Discover how transposon technology is being reimagined as a precise genetic engineering tool to create high-performing CHO cell lines for biotherapeutic production with enhanced metabolic and glycan profiles.

  2. Designing IND-Enabling Toxicity Studies For Complex Drug Modalities 8/6/2025

    Traditional toxicity studies don’t always fit today’s complex drug modalities. Watch as experts discuss how we’re adapting small molecule IND-enabling studies to meet modern therapeutic challenges.

  3. Discovery Studies: An Agile Approach To Early Data For Quicker Decisions 8/6/2025

    Discover the power of discovery research, key trends shaping early-phase drug development, and two exclusive case studies from our Sacramento facility.

  4. Random And Semi-Targeted Integration In Cell Line Development 8/5/2025

    While semi-targeted approaches may offer precision, uncover how they may fall short in overall efficiency and productivity, especially in late-stage manufacturing.

  5. Accelerating Gene Therapy Development For NEDAMSS 7/15/2025

    Discover how one family's race against time led to the creation of a groundbreaking gene therapy for their daughter, just 14 months after her ultra-rare disease diagnosis.

  6. Solving The Inhalation Puzzle: A CDMO's Guide To Dry Powder Development 7/9/2025

    Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

  7. New Approaches To Tailored Release Profiles 7/7/2025

    Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

  8. Securing A Treatment Through Grit And Collaboration 7/3/2025

    Discover how one family defied the odds — bringing a lifesaving gene therapy from idea to treatment in just 14 months after a devastating rare disease diagnosis.

  9. Creating Your ADC Supply Chain 6/26/2025

    Antibody-drug conjugates (ADCs) are on the rise. Supply chains to serve ADC developers can be complicated, and spread out. Reza Oliyai has some key interpretations of how these therapies can string together optimal - and at times far-reaching - supply chains.

  10. Your CDMO Knows A Lot - Are You Listening? 6/26/2025

    Our three experienced panelists weigh in on how sponsors should take advantage of what CDMOs know from experience in quality, regulatory, and other aspects of development and processing.